secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0000899923-23-000064
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics COO Nicole Lambert to step down Oct 31; remains consultant through Mar 2024
--------------------------------------------------------------------------------

- COO Nicole Lambert will depart as of Oct 31, 2023; will provide consulting services through Mar 31, 2024.
- Lambert receives weekly consulting fee of $4,951.92 and continued equity vesting during consulting period.
- Outstanding RSUs scheduled to vest within one year post-Separation Date will accelerate at Mar 31, 2024.
- Company reaffirmed FY2023 revenue and non-GAAP guidance previously provided on Sep 19 investor day.
- Departure not due to any disagreement with company's operations, policies, or procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000064/0000899923-23-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000064/mygn-20231004.htm
  HTML page:      https://secwatch.observer/filing/0000899923-23-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer